Detalhe da pesquisa
1.
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
Diabetologia
; 67(5): 822-836, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388753
2.
Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort.
Lancet Diabetes Endocrinol
; 12(2): 119-131, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142707
3.
Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Diabetes Care
; 43(8): 1948-1957, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534728
4.
Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957.
Diabetes Care
; 43(12): e202-e203, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33218985